Companies

Drugs Made In America Acquisition II Corp.

DMII, DMIIR, DMIIU · CIK 0002040475 · operating

$9.98+0.00%Last updated Mar 2, 6:23 PM

Key Statistics

Valuation

Market Cap$654.44M
P/E
Fwd P/E
PEG
P/S
P/B
EV/EBITDA
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE
ROA
FCF Margin

Financial Health

Current Ratio
Debt/Equity
Free Cash Flow
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta
52W High$10.01
52W Low$9.86

About Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp. is a special purpose acquisition company (SPAC) incorporated in 2024 and headquartered in Fort Lauderdale, Florida. As a blank check company, it currently has no significant operating business. The company was formed for the purpose of identifying and executing a business combination with one or more operating enterprises through a merger, share exchange, asset acquisition, or similar transaction.

The company has not yet identified a target business or completed any combination transaction. Until such time, it operates without meaningful revenue streams or business segments. The company maintains no established employee base or geographic operations beyond its status as a shell entity registered on the Nasdaq.

Annual Reports (10-K) · 0 filings

No 10-K filings found.